M&A News: Genmab (NASDAQ:GMAB) Is Acquiring ProfoundBio for $1.8B

Transactions in Connection with Share Buy-back Program

Analysts Offer Insights on Healthcare Companies: Kiora Pharmaceuticals (KPRX) and Genmab (GMAB)

Transactions in Connection with Share Buy-back Program

Completion of share buy-back program

Genmab Announces Initiation of Share Buy-Back Program

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab

Passing of Genmab A/S’ Annual General Meeting

Transactions in connection with share buy-back program

Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Springworks Therapeutics (SWTX) and Genmab (GMAB)

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Transactions in connection with share buy-back program